Financial News
Crispr Therapeutics Ag (NQ: CRSP )
Historical Prices
Year:
| Date | Open | High | Low | Close | Volume | Change (%) |
|---|---|---|---|---|---|---|
| Nov 30, 2021 | 77.38 | 80.50 | 77.23 | 79.90 | 1,473,108 | +1.92(+2.46%) |
| Nov 29, 2021 | 79.58 | 80.75 | 76.71 | 77.98 | 1,398,825 | -0.81(-1.03%) |
| Nov 26, 2021 | 79.57 | 82.00 | 78.46 | 78.79 | 1,176,066 | -2.13(-2.63%) |
| Nov 24, 2021 | 79.49 | 81.51 | 77.47 | 80.92 | 2,396,965 | +0.84(+1.05%) |
| Nov 23, 2021 | 80.07 | 80.46 | 77.42 | 80.08 | 1,917,401 | -0.21(-0.27%) |
| Nov 22, 2021 | 82.42 | 82.42 | 80.06 | 80.29 | 1,470,636 | -2.15(-2.60%) |
| Nov 19, 2021 | 83.01 | 83.98 | 81.92 | 82.44 | 1,060,038 | -0.64(-0.77%) |
| Nov 18, 2021 | 86.48 | 87.76 | 82.90 | 83.08 | 1,404,319 | -3.00(-3.49%) |
| Nov 17, 2021 | 86.31 | 86.92 | 84.61 | 86.08 | 856,404 | -0.50(-0.58%) |
| Nov 16, 2021 | 84.98 | 87.20 | 84.51 | 86.58 | 947,453 | +1.50(+1.76%) |
| Nov 15, 2021 | 89.03 | 89.68 | 84.31 | 85.08 | 1,820,831 | -3.85(-4.33%) |
| Nov 12, 2021 | 88.07 | 89.29 | 87.02 | 88.93 | 1,060,055 | +1.01(+1.15%) |
| Nov 11, 2021 | 88.66 | 89.70 | 87.31 | 87.92 | 967,601 | -2.53(-2.80%) |
| Nov 10, 2021 | 90.70 | 90.45 | 1,876,705 | -0.82(-0.90%) | ||
| Nov 09, 2021 | 94.12 | 95.00 | 90.75 | 91.27 | 1,142,409 | -2.87(-3.05%) |
| Nov 08, 2021 | 90.82 | 94.90 | 90.80 | 94.14 | 1,266,532 | +3.90(+4.32%) |
| Nov 05, 2021 | 93.08 | 93.95 | 89.55 | 90.24 | 1,548,149 | -2.86(-3.07%) |
| Nov 04, 2021 | 95.62 | 95.88 | 90.14 | 93.10 | 2,115,875 | -3.78(-3.90%) |
| Nov 03, 2021 | 95.60 | 96.98 | 94.80 | 96.88 | 1,137,033 | +1.04(+1.09%) |
| Nov 02, 2021 | 95.66 | 98.58 | 94.35 | 95.84 | 1,157,553 | +0.38(+0.40%) |
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
